Your browser doesn't support javascript.
loading
Predicting optimal use of continuous glucose monitors in adolescents with type 1 diabetes: It's about benefit and burden.
Messer, Laurel H; Cook, Paul F; Lowe, Nancy K; Hood, Korey K; Driscoll, Kimberly A; Hernandez, Teri L.
Afiliación
  • Messer LH; Barbara Davis Center, University of Colorado School of Medicine, Aurora, CO, United States of America; College of Nursing, University of Colorado Anschutz Medical Campus, Aurora, CO, United States of America. Electronic address: Laurel.Messer@cuanschutz.edu.
  • Cook PF; College of Nursing, University of Colorado Anschutz Medical Campus, Aurora, CO, United States of America.
  • Lowe NK; College of Nursing, University of Colorado Anschutz Medical Campus, Aurora, CO, United States of America.
  • Hood KK; Department of Pediatrics, Stanford University School of Medicine, Palo Alto, CA, United States of America.
  • Driscoll KA; University of Florida, Diabetes Institute, Gainesville, FL, United States of America.
  • Hernandez TL; College of Nursing, University of Colorado Anschutz Medical Campus, Aurora, CO, United States of America; Department of Medicine, Division of Endocrinology, Metabolism, and Diabetes, University of Colorado, Aurora, CO, United States of America; Children's Hospital Colorado, Aurora, CO, United States
J Pediatr Nurs ; 62: 23-29, 2022.
Article en En | MEDLINE | ID: mdl-34861605
ABSTRACT

PURPOSE:

Youth with type 1 diabetes (T1D) often use Continuous Glucose Monitoring (CGM) devices; however, many do not wear them consistently enough to obtain optimal glycemic benefit. This study aimed to identify demographic and psychosocial predictors of optimal CGM use in adolescents with T1D to inform nurse-led interventions to improve adherence. DESIGN AND

METHODS:

Cross-sectional survey data from youth (12-19 years) using CGM were analyzed to determine whether perceived benefits/burdens of CGM, self-efficacy, and coping predicted being a "CGM Optimizer" (wearing CGM 6-7 days/week) or "CGM Sub-user."

RESULTS:

Of 282 adolescents (54% female), 161 were CGM Optimizers and 121 were CGM Sub-Users. Optimizers were younger (15.91 ± 2.17 years vs. 16.79 ± 2.17, p = 0.001), more likely non-Hispanic White (91.9% vs 83.5%, p = 0.029), and more likely to have private insurance (82.0% vs. 69.4%, p = 0.009). Every 1-point increase on Benefits of CGM scale was associated with 2.8 times greater odds of being an Optimizer (OR = 2.82, 95% CI 1.548-5.132, p = 0.001), and every 1-point increase on the Burdens of CGM scale was associated with a 52% decrease in odds (OR = 0.48, 95% CI = 0.283-0.800, p = 0.005), with final logistic regression model (including only these two predictors) explaining 22.3% of variance.

CONCLUSION:

CGM Optimizing adolescents were more likely to perceive higher benefit and lower burden of CGM. PRACTICAL IMPLICATIONS Nurse-led interventions to promote benefits of CGM and mitigate burden may help youth increase adherence with CGM to achieve glycemic benefit.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 1 Tipo de estudio: Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Female / Humans / Male Idioma: En Revista: J Pediatr Nurs Asunto de la revista: ENFERMAGEM / PEDIATRIA Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 1 Tipo de estudio: Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Female / Humans / Male Idioma: En Revista: J Pediatr Nurs Asunto de la revista: ENFERMAGEM / PEDIATRIA Año: 2022 Tipo del documento: Article